Search Results

FILTER BY

1 - 5 of 5 matches

Sort by:
  • PresentationTCT 2020

    TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

    Presenter:  

    Benjamin Peterson

    October 15, 2020

  • PresentationSCAI 2020

    Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

    Presenter:  

    Benjamin E. Peterson

    May 21, 2020

  • PresentationACC 2020

    EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

    Presenter:  

    Deepak L. Bhatt

    March 30, 2020

  • PresentationAHA 2019

    Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

    Presenter:  

    Matthew Budoff

    November 18, 2019

  • PresentationAHA 2018

    REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

    Presenter:  

    Deepak L Bhatt

    November 16, 2018